Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

The Jak/STAT pathway: A focus on pain in rheumatoid arthritis

Simon, Lee S., Taylor, Peter C., Choy, Ernest H., Sebba, Anthony, Quebe, Amanda, Knopp, Kelly L. and Porreca, Frank 2021. The Jak/STAT pathway: A focus on pain in rheumatoid arthritis. Seminars in Arthritis and Rheumatism 51 (1) , pp. 278-284. 10.1016/j.semarthrit.2020.10.008
Item availability restricted.

[img] PDF - Accepted Post-Print Version
Restricted to Repository staff only until 18 December 2021 due to copyright restrictions.
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (555kB)

Abstract

Pain is a manifestation of rheumatoid arthritis (RA) that is mediated by inflammatory and non-inflammatory mechanisms and negatively affects quality of life. Recent findings from a Phase 3 clinical trial showed that patients with RA who were treated with a Janus kinase 1 (Jak1) and Janus kinase 2 (Jak2) inhibitor achieved significantly greater improvements in pain than those treated with a tumor necrosis factor blocker; both treatments resulted in similar changes in standard clinical measures and markers of inflammation. These findings suggest that Jak1 and Jak2 inhibition may relieve pain in RA caused by inflammatory and non-inflammatory mechanisms and are consistent with the overarching involvement of the Jak-signal transducer and activator of transcription (Jak/STAT) pathway in mediating the action, expression, and regulation of a multitude of pro- and anti-inflammatory cytokines. In this review, we provide an overview of pain in RA, the underlying importance of cytokines regulated directly or indirectly by the Jak/STAT pathway, and therapeutic targeting of the Jak/STAT pathway in RA. As highlighted herein, multiple cytokines directly or indirectly regulated by the Jak/STAT pathway play important roles in mediating various mechanisms underlying pain in RA. Having a better understanding of these mechanisms may help clinicians make treatment decisions that optimize the control of inflammation and pain.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Publisher: Elsevier
ISSN: 0049-0172
Date of First Compliant Deposit: 22 January 2021
Date of Acceptance: 23 November 2020
Last Modified: 26 Jan 2021 06:18
URI: http://orca.cardiff.ac.uk/id/eprint/137891

Actions (repository staff only)

Edit Item Edit Item